Age-related macular degeneration (AMD) is a leading cause of blindness in aged individuals. Recent advances have highlighted the essential role of immune processes in the development, progression and treatment of AMD. In this Review we discuss recent discoveries related to the immunological aspects of AMD pathogenesis. We outline the diverse immune cell types, inflammatory activators and pathways that are involved. Finally, we discuss the future of inflammation-directed therapeutics to treat AMD in the growing aged population.

Original languageEnglish
Pages (from-to)438-451
Number of pages14
JournalNature Reviews Immunology
Issue number6
StatePublished - Jun 2013


Dive into the research topics of 'Immunology of age-related macular degeneration'. Together they form a unique fingerprint.

Cite this